TRACON Pharmaceuticals, Inc.

TCON · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$8,564$17,433$24,072$32,131
Short-Term Investments$0$0$0$3,999
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$526$795$864$784
Total Curr. Assets$9,090$18,228$24,936$36,914
Property Plant & Equip (Net)$942$51$50$16
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$67$246$0
Tax Assets$0$0$0$0
Other NC Assets$73$1,123$1,325$508
Total NC Assets$1,015$1,241$1,621$524
Other Assets$0$0$0$0
Total Assets$10,105$19,469$26,557$37,438
Liabilities
Payables$2,544$3,923$4,943$1,725
Short-Term Debt$236$10,005$1,538$3,136
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,402$8,443$7,195$5,682
Total Curr. Liab.$10,182$22,371$13,676$10,543
LT Debt$0$0$0$1,391
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$4,249$0$432
Total NC Liab.$732$4,249$1,167$1,823
Other Liabilities$0$0$0$0
Cap. Leases$236$198$147$418
Total Liabilities$10,914$26,620$14,843$12,366
Equity
Pref Stock$0$0$0$0
Common Stock$44$23$19$15
Retained Earnings-$240,499-$236,911-$207,776-$179,109
AOCI$0$0$0$0
Other Equity$239,646$229,737$219,471$204,166
Total Equity-$809-$7,151$11,714$25,072
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,105$19,469$26,557$37,438
Net Debt-$8,328-$7,428-$22,534-$27,604